• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpropenes

3-(4,6-Dimethylpyrimidin-2-yl)amino-1-{2-[3-(prop-1-en-2-yl)phenyl]propan-2-yl}urea

The compound 3-(4,6-Dimethylpyrimidin-2-yl)amino-1-{2-[3-(prop-1-en-2-yl)phenyl]propan-2-yl}urea (CAS No. 380333-81-3) is a highly specialized organic molecule with significant potential in the fields of pharmacology and materials science. This compound is characterized by its unique structural features, which include a pyrimidine ring, a urea group, and an isopropenyl-substituted phenylpropane moiety. These structural elements contribute to its distinctive chemical properties and biological activity.

Recent studies have highlighted the importance of pyrimidine derivatives in drug discovery, particularly in the development of antiviral and anticancer agents. The presence of the 4,6-dimethylpyrimidin-2-amino group in this compound suggests potential applications in inhibiting key enzymes or receptors involved in disease pathways. For instance, researchers have reported that similar pyrimidine-based compounds exhibit potent inhibitory activity against cyclin-dependent kinases (CDKs), which are critical targets in cancer therapy.

The isopropenyl-substituted phenylpropane moiety further enhances the compound's versatility. This group is known to improve the molecule's lipophilicity, which is essential for its absorption and bioavailability. Recent advancements in medicinal chemistry have emphasized the role of such substituents in optimizing drug-like properties, including solubility and permeability. Moreover, the propenyl group introduces a degree of unsaturation that could potentially participate in π–π interactions with biological targets, thereby enhancing binding affinity.

From a synthetic standpoint, the construction of this compound involves a multi-step process that combines principles from organic synthesis and catalysis. Key steps include the formation of the pyrimidine ring via a Biginelli-type reaction, followed by amino group substitution and urea coupling. The use of microwave-assisted synthesis has been shown to significantly accelerate these reactions while maintaining high yields and purity levels. Such methodologies are increasingly favored in modern drug development due to their efficiency and sustainability.

Biological evaluations of this compound have revealed promising results in preclinical models. For example, studies conducted on human cancer cell lines have demonstrated selective cytotoxicity, suggesting its potential as an anticancer agent. Additionally, assays assessing its antiviral activity against influenza A virus have shown moderate inhibition of viral replication. These findings underscore the compound's broad applicability across diverse therapeutic areas.

In terms of applications beyond pharmacology, this compound has also been explored for its potential in materials science. Its rigid structure and functional groups make it a candidate for use in supramolecular chemistry and self-assembled monolayers. Researchers have reported that derivatives of this compound can form ordered nanostructures under specific conditions, which could be harnessed for applications in electronics or sensors.

Looking ahead, ongoing research is focused on further optimizing this compound's properties through structural modifications. For instance, efforts are being made to introduce additional functional groups that could enhance its selectivity or reduce off-target effects. Furthermore, computational modeling techniques such as molecular docking and dynamics simulations are being employed to better understand its interaction with biological targets at the atomic level.

In conclusion, 3-(4,6-Dimethylpyrimidin-2-yl)amino-1-{2-[3-(propenlyl)phenyl]propanoyl}urea (CAS No. 380333-) represents a versatile and promising molecule with applications spanning drug discovery and materials science. Its unique structure and favorable properties make it an attractive candidate for further investigation and development across multiple disciplines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)